Methods and kits for determining a personalized treatment regimen for a subject suffering from a pathologic disorder
AssigneeYissum Research Development Company of the Hebrew University of Jerusalem
InventorYoav SMITH
Life of this patent
Estimating the term…
Abstract
The invention relates to methods and kits for determining and optimizing a personalized treatment regimen for a subject suffering from a pathologic disorder based on calculating the value of M, that indicates the ability of said subject to eliminate said disorder. The invention specifically relates to optimization of interferon treatment of viral disorders.
Claims20
A method for determining a personalized treatment regimen for a subject suffering from a pathologic disorder, said method comprises the step of:
- a. Calculating the value of M, wherein said value indicates the ability of said subject to eliminate said disorder;
- b. Determining the value of M1, said value indicates the minimal ability required for eliminating said disorder;
- c. providing the dose A1 and number B1 of administrations of said dose to obtain an amount C1 of said medicament required for eliminating said disorder in subjects having a value of M that is equal or above said M1 value, wherein A1*B1=C1;
- d. Calculating the dose A and number B of administrations of said dose A to obtain an amount C1 required for said subject having said M determined/calculated in step (a), wherein said A=A1/(M1/M) and B=B1*(M1/M);
- thereby at least one of determining and optimizing the treatment regimen for said subject.
A kit for determining and/or optimizing a personalized treatment regimen for a subject suffering from a pathologic disorder comprising:
- a. detecting molecules specific for determining the level of expression of at least one of ISG15, IFIT1, IFIT2, IFITM3, IFI44L, IFIT3, IFIT5, OAS1, OAS2, OAS3, OASL, HERC5, USP18, RSAD2, MX1, IFI44L, DDX58, UBE1L, UBE2L6, IFI27, IFIH1, TLR7, IRF7, IFI6, STAT1, IFI44, EIF2AK2 and DHX58 genes in a biological sample, wherein said detecting molecules are selected from isolated detecting nucleic acid molecules and isolated detecting amino acid molecules;
- b. means for calculating the M value of a tested subject, wherein said value indicates the ability of said subject to eliminate said disorder;
- c. means for calculating the value of M1 or a standard M1 value calculated for a responder population, said M1 value indicates the minimal ability required for eliminating said disorder;
- and
- d. means for calculating the dose A and number B of administrations of said dose A to obtain an amount C of said medicament required for said subject.
A computer software product for determining and/or optimizing a personalized treatment regimen for a subject suffering from a pathologic disorder, the product comprising a computer readable medium in which program instructions are stored, which instructions, when read by a computer, cause the computer to
- a. Calculate and/or determine the value of M, wherein said value indicates the ability of said subject to eliminate said disorder;
- b. Determine the value of M1, said value indicates the minimal ability required for eliminating said disorder;
- c. calculate the dose A and number B of administrations of said dose A to obtain an amount C required for said subject having said M determined/calculated in step (a), from predetermined dose A1 and number B1 of administrations of said dose, using the formula of A=A/(M1/M) and B=B1*(M1/M).
Dependencies are inferred from the claim text.